Hummer Financial Advisory Services Inc Gsk PLC Transaction History

Hummer Financial Advisory Services Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 11, 2022	BUY	$40.23 - $47.74 $20,115 - $23,870	500 Added 10.69%	5,177 $228,000
Q4 2021 Jan 19, 2022	SELL	$38.88 - $45.31 $19,440 - $22,655	-500 Reduced 9.66%	4,677 $209,000
Q2 2021 Jul 28, 2021	BUY	$36.52 - $41.46 $189,064 - $214,638	5,177 New	5,177 $209,000
Q3 2020 Oct 16, 2020	SELL	$38.11 - $42.99 $208,728 - $235,456	-5,477 Closed	0 $0
Q2 2020 Jul 06, 2020	BUY	$37.87 - $43.58 $7,573 - $8,716	200 Added 3.79%	5,477 $227,000
Q1 2020 Apr 20, 2020	BUY	$32.47 - $48.83 $13,312 - $20,020	410 Added 8.42%	5,277 $203,000
Q4 2019 Feb 10, 2020	BUY	$42.0 - $48.25 $204,414 - $234,832	4,867 New	4,867 $231,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Hummer Financial Advisory Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hummer Financial Advisory Services Inc with notifications on news.